Abstract
Ovalbumin (OVA) is widely used in allergy research. OVA peptide 323-339 has been reported to be responsible for 25-35% of isolated BALB/c mouse T-cell response to intact OVA. An investigation of whether OVA and OVA 323-339 molecules can induce equivalent in vivo and in vitro immune responses was conducted. Eight-week-old BALB/c mice were randomly divided into three groups: OVA, OVA 323-339 and saline. On days 0, 7, 14, mice were intraperitoneally injected with 25 μg OVA or OVA 323-339 absorbed on 300 μg Alum, or saline; on days 21-23, all groups were challenged intranasally with either 20 μl of 1% OVA, 1% OVA 323-339 or saline. On day 28, after killing, splenocytes were isolated and cultured under the stimulus of each allergen or medium. Evaluated by hematoxylin/eosin and major basic protein immunohistochemical stainings, OVA and OVA 323-339 induced similar lung inflammation. Interestingly, significant serum total IgE and OVA-specific IgE were observed in OVA mice when compared to saline control. OVA 323-339 mice showed higher serum OVA-specific IgE, OVA 323-339-specific IgE, IL-4 and lower IFN-γ similar to OVA mice. The proliferative response to OVA was found in cultured splenocytes of both OVA and OVA 323-339 mice, while the similar proliferative response to OVA 323-339 was only observed in the splenocytes of OVA 323-339-sensitized and challenged mice. Although OVA 323-339 induced a Th2-like response in the mouse model as did OVA, OVA 323-339 has clearly limited immunogenic potency to activate OVA-sensitized and challenged mice splenocytes, unlike OVA. © 2010 Blackwell Publishing Ltd.
Cite
CITATION STYLE
Sun, L. Z., Elsayed, S., Aasen, T. B., Van Do, T., Aardal, N. P., Florvaag, E., & Vaali, K. (2010). Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic mice: Humoral and cellular aspects. Scandinavian Journal of Immunology, 71(5), 329–335. https://doi.org/10.1111/j.1365-3083.2010.02382.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.